After more than half a century as a private company, family-owned chemicals distributor Redox could now be tossing up a listing for 2022.
The 56-year-old business, founded in 1965 by Roland Coneliano, has got law firm Herbert Smith Freehills filing documents with the corporate regulator that suggest an IPO is a possibility.
Despite a challenging environment, Redox’s annual report reveals it generated $796.3 million sales in the year to June 30, which was up 10.8 per cent on the year before.
If it does pursue a listing next year, it’s likely to be in good company, with Chemist Warehouse, Cotton On and Australian Venue Co already in the pipeline.
It’s pipeline time of year, and while fund managers and equity capital markets bankers are all feeling a bit battered, it’s time to talk about the IPO pipeline.